Representative before the EPO

Employment test 51 - 200 employees
Company dna mathys and squire llp
no operation time available
Headquarter in London and 5 offices
active in Legal Services and Matchmaking and Trading

Representative before the EPO

Employment test 501 - 1000 employees
Company dna marks and clerk llp
operating since 1887
Headquarter in London and 16 offices
active in Legal Services, IP Consulting, and Matchmaking and Trading

We have observed 24 EP applications Thomas Zvesper has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 14, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11714488

IMMUNE THERAPY

IPC classification:
A61K 39/21, C07K 14/16
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP11745103

HSA-RELATED COMPOSITIONS AND METHODS OF USE

IPC classification:
A61K 38/38, C07K 14/765
Applicant:
MedImmune, LLC
Agent:
Thomas Zvesper, Mathys & Squire LLP
Agent:
Jonathan David Myers, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP11738959

ANTIBODY DERIVATIVES

IPC classification:
A61K 39/395, C07K 16/30, C12N 9/88
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP13159810

Method and apparatus for rehydration of lyophilized biologic materials

IPC classification:
A61F 2/00, A61J 1/10, B65D 81/00
Applicant:
C.R. Bard Inc.
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
The patent has been granted
EP13191140

Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof

IPC classification:
C12N 5/0735, C12N 5/074
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP12832188

BIORESORBABLE DRUG DELIVERY MATRICES BASED ON CROSS-LINKED POLYSACCHARIDES, DOSAGE FORMS DESIGNED FOR DELAYED/CONTROLLED RELEASE

IPC classification:
A61K 9/00
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP13709511

FORMULATION COMPRISING CRH AND ALPHA-2-MACROGLOBULIN

IPC classification:
A61K 38/22, A61K 38/33, A61K 38/57, A61K 47/42, A61P 31/14
Applicant:
Aimsco Limited
Agent:
Thomas Zvesper, Mathys & Squire LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13181253

Macrocyclic lactone compounds and methods for their use

IPC classification:
A61F 2/00, A61F 2/90, A61F 2/92, A61K 9/00, A61K 31/436, A61K 31/453, A61K 31/787, A61K 47/00, A61L 27/34, A61L 27/54, A61L 29/08, A61L 29/16, A61L 31/00, A61L 31/10, A61L 31/16, A61P 9/00
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12842115

FUNCTIONALIZED NANOPARTICLES FOR INTRACELLULAR DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES

IPC classification:
G01N 33/53
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13191150

Molded articles having partially embedded elements and a process for preparing the same

IPC classification:
B29C 39/10
Agent:
Thomas Zvesper, Mathys & Squire LLP
Status:
PATENT GRANTED
EP13785585

ASSAY FOR ASSESSMENT OF ENDOSOMAL TRANSPORT

IPC classification:
G01N 33/50
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
PATENT GRANTED
EP14708981

CELL COMPOSITIONS DERIVED FROM DEDIFFERENTIATED REPROGRAMMED CELLS

IPC classification:
C12N 5/00, C12N 5/071
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP14717903

3-DIMENSIONAL LARGE CAPACITY CELL ENCAPSULATION DEVICE ASSEMBLY

IPC classification:
A61F 2/02
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP14721621

IN VITRO DIFFERENTIATION OF PLURIPOTENT STEM CELLS TO PANCREATIC ENDODERM CELLS (PEC) AND ENDOCRINE CELLS

IPC classification:
C12N 5/0735
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP11858565

HSA-RELATED COMPOSITIONS AND METHODS OF USE

IPC classification:
A61K 38/38, A61K 47/48, C07K 14/765
Applicant:
MedImmune, LLC
Agent:
Thomas Zvesper, Mathys & Squire LLP
Agent:
Christopher Spencer Winter, MedImmune Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12195358

Treatment of diseases

IPC classification:
A61K 39/395, A61K 39/42, A61P 17/06, A61P 25/00, A61P 25/28, A61P 37/00, C07K 16/06, C07K 16/10
Applicant:
Aimsco Limited
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11761230

MOSQUITOCIDAL XENORHABDUS, LIPOPEPTIDE AND METHODS

IPC classification:
A01N 37/46, A01N 63/02, A01P 7/04, A61K 35/74, A61K 38/03
Applicant:
Wisconsin Alumni Research Foundation (WARF)
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
PATENT GRANTED
EP15752705

SOY-BASED CHEESE

IPC classification:
A23C 19/00
Agent:
Thomas Zvesper, Marks & Clerk LLP
Agent:
Novitas Patent AB
Status:
EXAMINATION REQUESTED
EP14725332

TOOLS AND INSTRUMENTS FOR USE WITH IMPLANTABLE ENCSAPSULATION DEVICES

IPC classification:
A61B 17/00, A61F 2/00, A61F 2/02, A61K 9/00, A61L 27/36, A61M 31/00
Agent:
Thomas Zvesper, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15774164

GROUND MEAT REPLICAS

IPC classification:
A23J 3/22
Agent:
Thomas Zvesper, Marks & Clerk LLP
Agent:
Novitas Patent AB
Status:
EXAMINATION REQUESTED
EP16857623

ARTIFICIAL BIOMEMBRANE USING SILK MATRIX AND METHOD OF MANUFACTURING THE SAME

IPC classification:
A61F 2/02, A61L 27/36, A61L 31/04
Agent:
Thomas Zvesper, Marks & Clerk LLP
Status:
Request for examination was made
EP16735524

METHOD FOR THE TREATMENT OF MALIGNANCIES

IPC classification:
C12N 15/87
Agent:
Thomas Zvesper, Marks & Clerk LLP
Status:
Request for examination was made
EP17166089

COMPOSITIONS FOR THE TREATMENT OF CHRONIC FATIGUE

IPC classification:
A61P 25/28
Agent:
Thomas Zvesper, Marks & Clerk LLP
Status:
The application has been published
EP17161141

MODIFICATIONS OF PEPTIDE COMPOSITIONS TO INCREASE STABILITY AND DELIVERY EFFICIENCY

IPC classification:
A61K 38/10, C07K 14/00, A61K 47/64
Agent:
Thomas Zvesper, Marks & Clerk LLP
Status:
Request for examination was made

Please Sign in to use this feature